We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 11-20 of 25,388

Supreme Court says isolated human genes cannot be patented

  • Quarles & Brady LLP
  • -
  • USA
  • -
  • June 17 2013

On June 13, 2013, the Supreme Court ruled unanimously that natural human genes, including isolated genes, cannot be patented, but cDNA that is

What does the future hold in view of the Supreme Court decision on isolated genes and cDNA?

  • White & Case LLP
  • -
  • USA
  • -
  • June 17 2013

In a long-anticipated ruling, the US Supreme Court acknowledged Myriad Genetics' contribution in discovering the location and sequence of the BRCA1

Upcoming deadline for PPACA Exchange Notice

  • Dorsey & Whitney LLP
  • -
  • USA
  • -
  • June 17 2013

The Patient Protection and Affordable Care Act ("Health Care Reform") created section 18B of the Fair Labor Standards Act (FLSA)1 requiring employers

Supreme Court permits DNA sampling of persons arrested, but not yet convicted, in Maryland v. King

  • Duane Morris LLP
  • -
  • USA
  • -
  • June 17 2013

We wrote earlier this year on the Fourth Amendment issue presented in Maryland v. King: whether a Maryland statute that allows the state to obtain

Supreme Court rules on reverse payment settlements in Federal Trade Commission v Actavis Inc

  • Fenwick & West LLP
  • -
  • USA
  • -
  • June 17 2013

Today, the U.S. Supreme Court held in Federal Trade Commission v. Actavis, Inc. that so-called "reverse payment" settlement agreements should be

Supreme Court’s deference to agreements by parties to arbitrate proves a double-edged sword, as court refuses to disturb arbitrator’s decision that parties’ contract authorized class arbitration

  • Chadbourne & Parke LLP
  • -
  • USA
  • -
  • June 17 2013

On June 10, 2013, the Supreme Court in Oxford Health Plans LLC v. Sutter, No. 12-135, unanimously held that a court cannot vacate an arbitrator's

Accommodations under the ADAAA: five sure ways to end up in court

  • Foley & Lardner LLP
  • -
  • USA
  • -
  • June 17 2013

The ADA Amendments Act of 2008 (ADAAA) unquestionably imposes extensive requirements on employers and covers a broad range of medical conditions. As

Health Care Reform Update, June 17th 2013

  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • -
  • USA
  • -
  • June 17 2013

On June 14th, CMS released a proposed rule with program integrity guidelines for the Health Insurance Marketplace. Among other things, the proposed

A Myriad of issues: Supreme Court rules on DNA patents

  • Alston & Bird LLP
  • -
  • USA
  • -
  • June 17 2013

On Thursday, June 14, 2013, the United States Supreme Court unanimously ruled that the isolated form of naturally occurring DNA molecules does not

Update on Supreme Court patent case: Association for Molecular Pathology v. Myriad (2013)

  • Lathrop & Gage LLP
  • -
  • USA
  • -
  • June 17 2013

Isolated DNA from a natural source is not eligible for patenting in the United States, but cDNA can be patent eligible except in situations where